These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19000555)

  • 1. Zotepine-induced spontaneous ejaculation.
    Wang PW; Wang SY; Huang CJ
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):571-3. PubMed ID: 19000555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Int Clin Psychopharmacol; 1992; 7(1):23-7. PubMed ID: 1352521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.
    Hwang TJ; Lin SK; Lin HN
    J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
    Huang WL; Chang LR
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
    Fleischhacker WW; Barnas C; Stuppäck CH; Sperner-Unterweger B; Miller C; Hinterhuber H
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 9. Convulsive seizures in schizophrenic patients induced by zotepine administration.
    Hori M; Suzuki T; Sasaki M; Shiraishi H; Koizumi J
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):161-7. PubMed ID: 1353125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
    Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
    Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
    [No Abstract]   [Full Text] [Related]  

  • 11. Three cases of alopecia areata induced by zotepine.
    Kubota T; Ishikura T; Jibiki I
    Acta Neurol (Napoli); 1993 Jun; 15(3):200-3. PubMed ID: 7901970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW; Stuppäck C; Barnas C; Unterweger B; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):61-3. PubMed ID: 2883685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zotepine in the treatment of acute hospitalized schizophrenic episodes.
    Kasper S; Quiner S; Barnas C; Fabisch H; Haushofer M; Sackel C; König P; Lingg A; Platz T; Rittmannsberger H; Stuppäck C; Willeit M; Zapotoczky HG
    Int Clin Psychopharmacol; 2001 May; 16(3):163-8. PubMed ID: 11354238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zotepine: a clinical review.
    Green B
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):181-6. PubMed ID: 19199377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy.
    Chen KC; Yang YK; Chen PS; Yeh TL; Yang MJ
    Psychiatry Clin Neurosci; 2003 Aug; 57(4):369-71. PubMed ID: 12839516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.